Although RET proto-oncogene mutations are the most frequent mutation in medullary thyroid carcinoma (MTC), the presence of RAS mutations in sporadic MTC has been documented by the induction of MTCs in rascal transgenic mice with v-Ha-ras under the control of a specific promoter [116]. Here, RET is linked to medullary thyroid gland carcinoma.